Metraipolis › archive › dc_57d47deae7cd

Development of novel lysosome-related signatures and their potential target drugs based on bulk RNA-seq and scRNA-seq for diabetic foot ulcers — Europe PMC PMID:38862997

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38862997
DOI
10.1186/s40246-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-01T02:46:18.225Z
SHA-256 of the archived text
1efaada875df805bc81f8975dfebe8bb04db298c59f9a4b00cf13be7814279bd
Stable URL of this page
https://metraipolis.com/documento/dc_57d47deae7cd

How to cite

Development of novel lysosome-related signatures and their potential target drugs based on bulk RNA-seq and scRNA-seq for diabetic foot ulcers — Europe PMC PMID:38862997 — Europe PMC (en), https://europepmc.org/article/MED/38862997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57d47deae7cd (Metraipolis archive dc_57d47deae7cd, sha256 1efaada875df805bc81f8975dfebe8bb04db298c59f9a4b00cf13be7814279bd)
BibTeX
@misc{dc57d47deae7cd,
  title = {Development of novel lysosome-related signatures and their potential target drugs based on bulk RNA-seq and scRNA-seq for diabetic foot ulcers — Europe PMC PMID:38862997},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38862997},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57d47deae7cd; sha256 1efaada875df805bc81f8975dfebe8bb04db298c59f9a4b00cf13be7814279bd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38862997. Agents can read the archived copy with the MCP tool read_document.